<DOC>
	<DOCNO>NCT00400907</DOCNO>
	<brief_summary>RATIONALE : Treatment diffuse large B-cell non-Hodgkin 's lymphoma may cause side effect secondary cancer later life . An observational study evaluate patient undergo six course combination chemotherapy without rituximab radiation therapy may help doctor predict patient 's response treatment help plan best treatment . PURPOSE : This observational study evaluate patient diffuse large B-cell non-Hodgkin 's lymphoma see well treatment clinical trial CAN-NCIC-LY9 work .</brief_summary>
	<brief_title>Observation Patients With Diffuse Large B-Cell Non-Hodgkin 's Lymphoma Treated Clinical Trial CAN-NCIC-LY9</brief_title>
	<detailed_description>OBJECTIVES : - Gain information long-term efficacy 6 course CHOP ( cyclophosphamide , doxorubicin hydrochloride , prednisone , vincristine ) -like chemotherapy v without rituximab ( plus involved-field radiotherapy primary bulky disease ) young patient good-prognosis diffuse large B-cell non-Hodgkin 's lymphoma treat protocol CAN-NCIC-LY9 . - Gain information late toxicity , include secondary neoplasm occur young good-prognosis patient treat protocol CAN-NCIC-LY9 . OUTLINE : This multicenter study . Patients successfully complete treatment protocol CAN-NCIC-LY9 follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 667 patient accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients recruit protocol CANNCICLY9 evaluate first plan final analysis June 2005 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>long-term effect secondary cancer therapy adult</keyword>
	<keyword>stage I adult diffuse large cell lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
</DOC>